Fact CheckerSign in

NCT06870305Not yet recruiting

Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis

Source: ClinicalTrials.gov · Last updated 25 Mar 2026

Brief summary (registry, in English)

The main objective is to evaluate the efficacy of a group-based mindfulness therapy programme in reducing distress associated with symptoms of UHR (Ultra High Risk) or FEP (first psychotic episode) compared with usual treatment. The secondary objectives were to study the efficacy of a group-based mindfulness intervention: on the reduction of psychotic symptoms; on the maintenance over time (6 months of follow-up) of the efficacy of the intervention on the distress associated with the symptoms of the UHR or PEP state; and on various dimensions associated with care: cognitive functions, anxiety, quality of life.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
270 (estimated)
First submitted
6 Mar 2025
Start date
Apr 2029
Primary completion date
Apr 2029
Lead sponsor
Centre Psychothérapique de Nancy
NCT number
NCT06870305

What you commit to

  • Study type: Interventional
  • Planned participants: 270
  • From Apr 2029 to the primary completion date, Apr 2029
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous episode of schizophrenic disorder, schizoaffective disorder or bipolar disorder
  • Previous antipsychotic treatment for more than 12 months

Other illness

  • Organic mental disorder or intellectual disability

Other

  • Serious suicidal/homicidal risk (but admissible if this risk has been resolved)
  • Insufficient French language skills
  • Adult incapable of giving consent and not under legal protection
  • Protection measure (guardianship/curatorship/court supervision) or under court supervision
  • Person deprived of liberty by judicial or administrative decision (including forced hospitalisation)
  • Persons in a life-threatening emergency
  • Not affiliated to a social security regime

Who the study is looking for

  • People aged between 18 and 30 validating the criteria for UHR or PEP status on the CAARMS scale and having a social functional impact (SOFAS score below 50 or a reduction of more than 30% in the score)

Age in the registry: 18 years to 30 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre Hospitalier Universitaire (CHU) de Brest
Coordinator of this site? Confirm its status
BrestFranceUnknown status
Centre Psychothérapique de Nancy
Coordinator of this site? Confirm its status
LaxouFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.